Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) FCF Margin (2016 - 2025)

Collegium Pharmaceutical has reported FCF Margin over the past 10 years, most recently at 59.89% for Q4 2025.

  • Quarterly results put FCF Margin at 59.89% for Q4 2025, up 1288.0% from a year ago — trailing twelve months through Dec 2025 was 42.15% (down 51.0% YoY), and the annual figure for FY2025 was 42.15%, up 972.0%.
  • FCF Margin for Q4 2025 was 59.89% at Collegium Pharmaceutical, up from 37.37% in the prior quarter.
  • Over the last five years, FCF Margin for COLL hit a ceiling of 93.1% in Q4 2021 and a floor of 699.39% in Q1 2022.
  • Median FCF Margin over the past 5 years was 38.13% (2025), compared with a mean of 1.43%.
  • Biggest five-year swings in FCF Margin: crashed -72236bps in 2022 and later surged 71839bps in 2023.
  • Collegium Pharmaceutical's FCF Margin stood at 93.1% in 2021, then tumbled by -46bps to 50.44% in 2022, then decreased by -3bps to 49.06% in 2023, then fell by -4bps to 47.01% in 2024, then increased by 27bps to 59.89% in 2025.
  • The last three reported values for FCF Margin were 59.89% (Q4 2025), 37.37% (Q3 2025), and 38.89% (Q2 2025) per Business Quant data.